The utility of pentraxin 3 and platelet-derived growth factor receptor beta as non-invasive biomarkers for prediction of cardiovascular risk in MAFLD patients
Abstract Background Metabolic-associated fatty liver disease (MAFLD) has emerged as the predominant form of chronic liver disease globally linked with heightened cardiovascular disease (CVD) risk, the leading cause of mortality among affected individuals. Aim This study aims to assess serum PTX3 (pe...
Saved in:
Main Authors: | Hanaa Badran (Author), Maha Elsabaawy (Author), Mahmoud Magdy (Author), Samar Ghanem (Author), Mohammed Said (Author), Mohamed Hamdy Torky (Author), Tamer Samir (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long Pentraxin PTX 3 and Faecal Calprotectin as a Non Invasive Biomarkers for Ulcerative Colitis
by: Sherif Ezzat, et al.
Published: (2017) -
Comparison of transient elastography and shear wave elastography in patients with MAFLD: A single-center experience
by: Kohla Mohamed Ahmed Samy, et al.
Published: (2024) -
The Role of Pentraxins: From Inflammation, Tissue Repair and Immunity to Biomarkers
Published: (2020) -
Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection
by: Siguan Liu, et al.
Published: (2014) -
Pentraxins and immunity
by: Priya Nagar, et al.
Published: (2014)